Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.

Human pathology - 1 Dec 2007

Kondo Tetsuo, Nakazawa Tadao, Murata Shin-ichi, Kurebayashi Junichi, Ezzat Shereen, Asa Sylvia L, Katoh Ryohei

Abstract excerpt

BRAF (7q24) encodes a serine/threonine protein kinase, and its expression level varies in different tissues. Although a high prevalence of BRAF mutation has been suggested as an important event in thyroid tumorigenesis, little is known about the expression pattern of B-Raf in the thyroid. Thus, we examined the expression of B-Raf in various neoplastic and nonneoplastic thyroid tissues and compared it with BRAF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Western
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Gene Expression

Share to Immunohistochemistry

Share to Proto-Oncogene Proteins B-raf

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 17714762
DOI: 10.1016/j.humpath.2007.04.014

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.PMID 17714762Read ↗

Expression analysis of B-Raf oncogene in V600E-negative benign and malignant tumors of the thyroid gland: correlation with late disease onset.Semantic proximity Read ↗

Roles of RAS and BRAF mutations in thyroid carcinogenesis.Semantic proximity Read ↗

The role of BRAF in the pathogenesis of thyroid carcinoma.Semantic proximity Read ↗

ERK phosphorylation is not increased in papillary thyroid carcinomas with BRAF(V600E) mutation compared to that of corresponding normal thyroid tissues.Semantic proximity Read ↗

Targeting BRAF in thyroid cancer.Semantic proximity Read ↗

High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy.Semantic proximity Read ↗

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.Semantic proximity Read ↗

B-Raf mutation: a key player in molecular biology of cancer.Semantic proximity Read ↗

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.Semantic proximity Read ↗

Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).Semantic proximity Read ↗

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.Semantic proximity Read ↗

Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.